IL6 and fatty liver disease: Despite obvious increased hepatic steatosis in HC-HMGB1−/−mice early, serum levels of ALT (marker of liver injury) and IL-6 (systemic inflammation) were not significantly higher compared to controls mice until 16 weeks (Additional file 3: Fig. S2A, B).